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Abstract
Background: Biological studies and medical application of stem cells often require the isolation of
stem cells from a mixed cell population, including the detection of cancer stem cells in tumor tissue,
and isolation of induced pluripotent stem cells after eliciting the expression of specific genes in adult
cells. Here we report the detection of Oct-4 mRNA and SSEA-1 protein in live carcinoma stem
cells using respectively molecular beacon and dye-labeled antibody, aiming to establish a new
method for stem cells detection and isolation.
Results: Quantification of Oct-4 mRNA and protein in P19 mouse carcinoma stem cells using
respectively RT-PCR and immunocytochemistry confirmed that their levels drastically decreased
after differentiation. To visualize Oct-4 mRNA in live stem cells, molecular beacons were designed,
synthesized and validated, and the detection specificity was confirmed using control studies. We
found that the fluorescence signal from Oct-4-targeting molecular beacons provides a clear
discrimination between undifferentiated and retinoic acid-induced differentiated cells. Using
deconvolution fluorescence microscopy, Oct-4 mRNAs were found to reside on one side of the
cytosol. We demonstrated that, using a combination of Oct-4 mRNA-targeting molecular beacon
with SSEA-1 antibody in flow cytometric analysis, undifferentiated stem cells can be clearly
distinguished from differentiated cells. We revealed that Oct-4 targeting molecular beacons do not
seem to affect stem cell biology.
Conclusion: Molecular beacons have the potential to provide a powerful tool for highly specific
detection and isolation of stem cells, including cancer stem cells and induced pluripotent stem (iPS)
cells without disturbing cell physiology. It is advantageous to perform simultaneous detection of
intracellular (mRNA) and cell-surface (protein) stem cell markers in flow cytometric analysis, which
may lead to high detection sensitivity and efficiency.
Background
Embryonic stem cells (ESCs) have the potential to indefi-
nitely self-renew and differentiate into any cell type [1],
and extensive studies have been carried out to take advan-
tage of these unique characteristics including tissue regen-
eration and repair [2-5]. In particular, recent advances in
creating induced pluripotent stem (iPS) cells using
human skin cells have opened a new avenue for the gen-
eration of stem cells without the use of embryos.
Although embryonic stem cells provide an excellent
source of cell lines for tissue repair and therapeutic appli-
cations, their embryonic origins can create ethical con-
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cerns and it is impossible to find cells that would have the
identical genetics to match that of a patient. Therefore, it
is very attractive to use iPS cells derived from a patient's
adult cells to differentiate into specialized cells for treating
specific diseases or repairing injured tissue. However, cur-
rently, the process of developing iPS cells is very ineffi-
cient – it was reported that only 10–20 iPS cell colonies
were obtained from 0.1 million initial fibroblasts [6,7].
Therefore, it is necessary to have an efficient method to
isolate iPS cells from mixed cell populations.
Another area of active research is cancer stem cells. In par-
ticular, embryonal carcinoma (EC) cells are pluripotent
stem cells derived from teratocarcinomas and are consid-
ered the malignant counterparts of human embryonic
stem (ES) cells [8,9]. EC cells can generate cancer cells
after differentiation and form tumors after transplanta-
tion. Since cancer stem cells are known to reside in
tumors, an effective therapy of cancer may require the spe-
cific detection and elimination of cancer stem cells in
tumor [10,11]. Therefore, it is important to develop new
technologies to effectively discriminate cancer stem cells
from other cancer cells using specific gene and/or protein
markers. It is also desirable to isolate cancer stem cells
from tumor tissue for in vitro analysis of cancer stem cell
biology.
Methods have been developed to isolate stem cells using
antibodies that specifically bind to cell surface marker
proteins [12-14], or based on transfection of plasmid with
the promoter and reporter genes [15,16]. It is also possi-
ble to identify peptides that bind to surface markers of
embryonal carcinoma cells (such as undifferentiated P19
cells) using a phage display library [17]. Although these
methods can provide decent purity in isolating stem cells,
each has limitations in its applicability. The strategy of tar-
geting cell surface proteins in detecting stem cells relies on
the available cell surface markers, which may be very lim-
ited; their expression levels may be too low for fluores-
cence-activated cell sorting (FACS) analysis. On the other
hand, it is impossible to detect cancer stem cells by trans-
fecting certain genes to cells in vivo, and the incorporation
of foreign genes into stem cell chromosomes for cell iso-
lation may cause concerns when these cells are used in
treating human disease. Therefore, it is necessary to
develop new methods for stem cell detection and isola-
tion with better robustness and safety.
In this work, we have developed a new method for detec-
tion and isolation of stem cells by targeting both an intra-
cellular marker (mRNA) and a cell surface marker (SSEA-
1 protein), using mouse EC cells as a model system. Spe-
cifically, we designed molecular beacons to target Oct-4
mRNA in live EC cells in addition to targeting SSEA-1 pro-
tein using dye-labeled antibodies, and used flow cytome-
try to demonstrate the effectiveness in processing a large
number of cells. Oct-4 is well-known key transcription
factor regulating the differentiation and its down-regula-
tion by siRNA induces differentiation of not only embry-
onic stem cells but also cancer stem cells [18,19].
Therefore, the level of Oct-4 mRNA in live stem cells can
be used as an effective marker to indicate the state of stem
cells (before and after differentiation). Oct-4 has also
been implicated as a marker of germ cell tumors. Here we
demonstrate that, by imaging the level of Oct-4 mRNA
using molecular beacons, undifferentiated normal and
cancer stem cells can be distinguished from other cells.
Results
Decrease in Oct-4 mRNA and protein levels in EC cells 
after differentiation
Retinoic acid (RA) treatment has been widely used to reg-
ulate gene expression. For example, DNA microarray anal-
ysis of ES-D3 cells showed the down-regulation of 18
genes and the up-regulation of 61 genes after RA treat-
ment [20]. RA treatment can also regulate many genes
[21] in EC cells, including Oct-4, and induce cell differen-
tiation to different cell types including neurons, glial cells
and fibroblasts, depending on RA concentration [22,23].
Extensive studies have indicated that Oct-4 is down-regu-
lated as stem cells start to differentiate.
As a positive control for molecular beacon based studies,
we have quantified the changes in Oct-4 mRNA level 4
days after RA treatment in P19 cells. Cells were exposed to
500 nM of RA for 2 days followed by 2 days of incubation
with medium absent of RA. As shown in Figure 1A, our
real-time PCR results indicate that RA treatment decreased
the Oct-4 mRNA level in differentiated cells to less than
1% of that in untreated EC cells. To check if decrease in
Oct-4 mRNA level reflects changes in Oct-4 protein level,
we carried out immunocytochemistry assays of Oct-4 pro-
tein before and after RA treatment using dye-labeled anti-
body for Oct-4. As demonstrated in Figure 1B, strong
fluorescence signals were observed in the nuclei of undif-
ferentiated cells, while there was essentially no signal after
RA treatment. Since Oct-4 is a transcription factor, it is not
surprising that the staining of Oct-4 protein is predomi-
nately in cell nucleus (Figure 1B).
Design and validation of Oct-4 targeting molecular 
beacons
We have designed molecular beacons to image changes in
Oct-4 mRNA level in live EC cells before and after differ-
entiation. Molecular beacons are dual-labeled antisense
oligonucleotide (ODN) probes with a fluorophore and a
quencher at each ends [24,25]. In the absence of a com-
plementary target, they form a stem-loop hairpin struc-
ture, and the fluorescence reporter (fluorophore) is
quenched by the quencher. Hybridization with the targetBMC Biotechnology 2009, 9:30 http://www.biomedcentral.com/1472-6750/9/30
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Changes of Oct-4 mRNA and protein levels 4 days after retinoic acid (RA) treatment in P19 embryonal carcinoma cells Figure 1
Changes of Oct-4 mRNA and protein levels 4 days after retinoic acid (RA) treatment in P19 embryonal carci-
noma cells. A. Real-time PCR result of Oct-4 mRNA level in undifferentiated (UD) and differentiated (RA treated) P19 cells. 
B. Immunocytochemistry of Oct-4 protein (Red) before (UD) and after (RA) differentiation. Cell nuclei were stained with 
Hoechst 33342 (Blue).
The cDNA sequence of mouse Oct-4 mRNA and the hybridization sites of Oct-4 targeting molecular beacons (MB1 – MB13) Figure 2
The cDNA sequence of mouse Oct-4 mRNA and the hybridization sites of Oct-4 targeting molecular beacons 
(MB1 – MB13).BMC Biotechnology 2009, 9:30 http://www.biomedcentral.com/1472-6750/9/30
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mRNA opens the stem-loop structure and physically sep-
arates the reporter from quencher, allowing a fluorescence
signal to be emitted upon excitation.
To ensure that there is good target accessibility in live-cell
detection of Oct-4 mRNA, we have designed and tested 13
molecular beacons (designated as MB1 to MB13) that tar-
get different sites on Oct-4 mRNA, as shown in Figure 2.
Target accessibility is one of the most important issues in
live-cell mRNA detection since, although a molecular bea-
con can be designed to have its probe sequence unique to
the target mRNA, the target sequence may not necessarily
be accessible in a living cell. Specifically, the probes need
to avoid targeting sequences that form secondary struc-
tures or are occupied by RNA-binding proteins [26] in
order to have a good level off signal.
As shown in Figure 2 and Table 1, thirteen molecular bea-
cons were designed to target different sites in Oct-4
mRNA, including siRNA binding sites (MB1, MB8,
MB12), the anti-sense oligonucleotide binding sites
(MB2) predicted using mFOLD http://www.idtdna.com/
Scitools/Applications/mFold/, loop site predicted by
mFOLD http://bioweb.pasteur.fr/seqanal/interfaces/
mfold-simple.html (MB3), the sites close to termination
codon (MB4) and translation initiation codon (MB5),
respectively, 5' untranslated region (MB6), and exon-exon
junctions (MB1, MB10, MB11). The target sequences for
MB7, MB9, and MB13 were chosen without any particular
reason. As a negative control, we used a random-sequence
molecular beacon (random beacon) which does not have
any complementary target in human and mouse genome.
All molecular beacons have Cy3 as the fluorophore and
BHQ2 as the quencher. After synthesis, these molecular
beacons were tested in solution to ensure that they have
an acceptable signal-to-background ratio (> 5).
Detection of Oct-4 mRNA in undifferentiated and 
differentiated EC Cells
It is well known that RA treatment induces P19 cells to dif-
ferentiate into glial, neuron and fibroblast-like cells [22],
and the Oct-4 expression level decreases significantly after
differentiation (Figure 1). We delivered each of the thir-
teen beacons synthesized into both undifferentiated and
differentiated cells by streptolysin O (SLO) and analyzed
with epi-fluorescence microscope. We could only observe
very low fluorescence signal from Oct-4 targeting molecu-
lar beacons MB1, MB5 – MB13 in undifferentiated cells, as
shown in Figure 3A (representative images), and the ran-
dom beacons used as a negative control did not give much
fluorescence signal in undifferentiated cells (Figure 3B).
We believe that the sites on Oct-4 mRNA targeted by MB1,
MB5-MB13 are not accessible for molecular beacons to
hybridize due to either the secondary structures formed at,
or the RNA-binding proteins bound to these regions.
However, MB2, MB3 and MB4 all showed strong fluores-
cence signal in undifferentiated cells, and much lower flu-
orescence signal in differentiated cells, as demonstrated
by Figures 3C and 3D, respectively. Flow cytometric anal-
ysis of hybridization of molecular beacons to Oct-4
mRNA confirmed that only MB2, MB3 and MB4 gave
shifts of fluorescence signal distribution in undifferenti-
ated cells compared with that in differentiated cells or ran-
dom beacon signal distribution in undifferentiated cells
(data not shown). We found that MB4 gave the highest
signal intensity in undifferentiated cells and therefore, in
the subsequent experiments, only MB4 was used.
Deconvolution microscopy of Oct-4 mRNA
We used deconvolution microscope to image and analyze
the localization of Oct-4 mRNA. As shown by the top
panel in Figure 4A, in most of the undifferentiated cell,
beacon signals (red) from detecting Oct-4 mRNA are
mostly localized on one side of the cell cytosol, and the
Table 1: The design of mouse Oct-4 targeting and negative control (random) molecular beacons*
Beacon ID Molecular Beacon Design
MB1 5'-Cy3-CGTCGCATACTCGAACCACATCCCGACG-BHQ2-3'
MB2 5'-Cy3-CAGCCCCTCCACCCACTTCTGGCTG-BHQ2-3'
MB3 5'-Cy3-CCGGTCATGTTCTTAAGGCTACCGG-BHQ2-3'
MB4 5'-Cy3-CGCAGTCCAGGTTCTCTTGTCTCTGCG-BHQ2-3'
MB5 5'-Cy3-CGGAGAGCCAGGTGTCCAGCCATCTCCG-BHQ2-3'
MB6 5'-Cy3-CCGGAGGGGCCTGGTGGAAAGATCCGG-BHQ2-3'
MB7 5'-Cy3-CCACAGAGCCCTGCTGACCCACTGTGG-BHQ2-3'
MB8 5'-Cy3-CAGGACCTAGTTCGCTTTCTCTTGTCCTG-BHQ2-3'
MB9 5'-Cy3-CGCAGCTTCTGGCGCCGGTTCTGCG-BHQ2-3'
MB10 5'-Cy3-CCGGAACATGTCCTGGGACTCCTCTTCCGG-BHQ2-3'
MB11 5'-Cy3-CGAGCGCATATCTCCTGAAGGGCTCG-BHQ2-3'
MB12 5'-Cy3-CGTGCCCCCAATACCTCTGAGCGCACG-BHQ2-3'
MB13 5'-Cy3-CCGTGGGATACAGCCCCCCCTGCACGG-BHQ2-3'
Random MB 5'-Cy3-CGACGCGACAAGCGCACCGATACGTCG-BHQ2-3'
* The underline indicates the stem sequence. Abbreviation: MB, molecular beacon; BHQ, black hole quencher.BMC Biotechnology 2009, 9:30 http://www.biomedcentral.com/1472-6750/9/30
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fluorescence signal intensity varied from cell to cell, indi-
cating the differences of Oct-4 expression level among
cells. As demonstrated previously, molecular beacon sig-
nal from targeting Oct-4 mRNA in differentiated cells was
very low, confirming that the beacon signal was specific.
We have also fluorescently labeled total RNA using
SytoRNA Select in both undifferentiated and differenti-
ated live cells. As shown in Figure 4B, it appears that there
was little difference in total RNA staining pattern in undif-
ferentiated and differentiated cells. This further confirms
the Oct-4 mRNA detection specificity using molecular
beacons.
Co-labeling of SSEA-1 protein and Oct-4 mRNA
It has been well established that undifferentiated EC cells
express a stage-specific embryonic antigen, SSEA-1 protein
on their surface. We therefore imaged SSEA-1 protein
using dye-labeled antibody in addition to targeting Oct-4
mRNA in live cancer stem cells to see if we could use both
signals in a flow cytometry analysis. SSEA-1 antibodies
conjugated with Alexa 647 were incubated with cells after
molecular beacon delivery by SLO. The fluorescence sig-
nals were then analyzed using a deconvolution micro-
scope. Shown in Figure 5A were images of fluorescence
signal from targeting Oct-4 mRNA (red) and SSEA-1 pro-
tein (green) in live undifferentiated and differentiated
(RA-treated) P19 cells. The top panel of Figure 5A demon-
Fluorescence signal from different molecular beacon designs Figure 3
Fluorescence signal from different molecular beacon designs. In A-D, left and right panels display respectively the 
undifferentiated (UD) and RA treated (differentiated) cells; top and bottom panels display respectively the epifluorescence 
images of beacons and the bright field images of the same cells. The same exposure time was used for all beacon fluorescence 
imaging. A and B. Random beacon used as negative control (A) and MB5 (B) gave very low signal. Signals from MB1, MB6-MB13 
were similar to that of MB5. C and D. MB3 (C) and MB4 (D) gave high signal levels, indicating good target accessibility.BMC Biotechnology 2009, 9:30 http://www.biomedcentral.com/1472-6750/9/30
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strates that signal (green) from SSEA-1 staining is quite
high in undifferentiated cells and is very low in differenti-
ated cells. As a negative control, random beacons were
delivered into cells before and after differentiation and
showed very weak signal in both cell types (red signal in
the top panel), in contrast to the SSEA-1 signal. With Oct-
4 targeting molecular beacons (MB4), strong fluorescence
signal (red) was detected in undifferentiated cell, together
with strong signal from SSEA-1 protein (lower panel in
Figure 5A), and only low beacon signal (red) can be
detected in differentiated cells, along with very low
(green) signal from SSEA-1. These imaging results show
clearly that signals from Oct-4 targeting beacons and
SSEA-1 stating using antibodies are highly correlated and
therefore could be used in detecting cancer stem cells with
higher sensitivity than using one marker only.
Flow cytometric analysis of SSEA-1 protein and Oct-4
mRNA expression in undifferentiated and differentiated
P19 cells using dye-labeled antibody and molecular bea-
cons, respectively, was performed. The rational is that
only a very small number of cancer stem cells (e.g., 1 in
1,000,000 cells) in tumor tissue, and therefore, in detect-
ing cancer stem cells, flow cytometry is likely the most effi-
cient method. In the flow cytometry assay, both
undifferentiated and RA treated cells were detached, and 1
μM of Oct-4 targeting molecular beacons was delivered by
SLO in suspension. Alexa 647 dye labeled SSEA-1 anti-
body was incubated after beacon delivery in serum-con-
taining medium for 30 min. Cells without Oct-4 antibody
and molecular beacon were used as control. As demon-
strated in Figure 5B, left panel, flow cytometry analysis of
cells without any probe showed no much difference in
terms of auto-fluorescence in both undifferentiated (left
top panel) and differentiated (left bottom panel) cells. In
Figure 5B, X-axis shows the relative fluorescence intensity
from Oct-4 mRNA and Y-axis shows the relative fluores-
cence intensity from dye-labeled SSEA-1 antibody. For
undifferentiated cells (right top panel), fluorescence sig-
nals from SSEA-1 protein (Y-axis) and Oct-4 mRNA (X-
axis) were significantly shifted compared to control cells
(left panel). In contrast, there were only relatively small
shifts of fluorescence signal from both SSEA-1 protein and
Oct-4 mRNA fluorescent signals in differentiated cells
(right bottom panel). The results shown in Figure 5B
clearly demonstrate that, using flow cytometry assays in
combination with two stem cell markers (Oct-4 mRNA
and SSEA-1 protein), cancer stem cells could be detected
from other tumor cells.
Discussion
Although cell surface markers can be used to detect stem
cells, medical applications of stem cell technology,
including the detection of iPS cells from a heterogeneous
cell population and the isolation of cancer stem cells from
tumor tissue often requires the specific targeting of intrac-
ellular stem cell markers, such as mRNAs. However, to our
knowledge, the detection of stem cell mRNA marker in
living cells has not been demonstrated. Here we report the
detection of Oct-4 mRNA and SSEA-1 protein in live car-
cinoma stem cells using respectively molecular beacons
and dye-labeled antibody, aiming to establish a new
method for stem cells detection and isolation. Although
in this work we used mouse embryonal carcinoma cells as
a model, the same approach is applicable in detecting iPS
and cancer stem cells. Live-cell detection of stem cell
marker mRNAs is also of importance in tracking embry-
onic stem cell differentiation and the isolation of other
stem cells such as progenitor cells by detecting specific
mRNAs that can discriminate target cells from other cells.
There are three important issues in detecting live stem
cells (including iPS cells and cancer stem cells) from het-
erogeneous cell population or tissue: detection specificity,
sensitivity, and efficiency. Although cell surface protein
markers can be used for detecting live stem cells, they have
very limited availability. Therefore, the detection of stem
cell marker mRNAs using molecular beacons is attractive
in that there are many mRNAs available for targeting and
the beacon based mRNA detection does not require cells
to be fixed or lysed. Clearly, detecting stem cells using
Deconvolution fluorescence imaging of Oct-4 mRNA and  total mRNA in live P19 cells, with cell nucleus stained with  Hoechst 33342 (blue) Figure 4
Deconvolution fluorescence imaging of Oct-4 mRNA 
and total mRNA in live P19 cells, with cell nucleus 
stained with Hoechst 33342 (blue). A. The cytosolic 
localization of Oct-4 mRNA (red) in undifferentiated (UD) 
and RA treated (differentiated) cells. B. Total RNA staining 
using SytoRNA Select dye (green) in undifferentiated (UD) 
and RA treated (differentiated) cells. Scale bar = 15 μm.BMC Biotechnology 2009, 9:30 http://www.biomedcentral.com/1472-6750/9/30
Page 7 of 10
(page number not for citation purposes)
multiple mRNA markers in combination with surface pro-
tein markers could increase both detection specificity and
sensitivity. Detection efficiency is also an important issue,
since the success rate of getting iPS cells is rather low: typ-
ically less than 0.01% of all cells transfected are converted
into iPS cells [27]. Further, cancer stem cells are very rare,
estimated as 1 in 100,000 to 1,000,000 cancer cells in
tumor tissue. Therefore, the use of a flow cytometry
method may be necessary to process a large number of
cells in detecting iPS cells or cancer stem cells.
For sensitive isolation of iPS cells, it may be necessary to
detect multiple stem cell markers. For example, concerting
skin cells to iPS cells requires specific expression of tran-
scription factors Oct-4, Sox2 and Nanog, as demonstrated
recently [6,7]. It is likely that the expression of these genes
has different levels in different cells when inducing them
into iPS. Therefore, it may be advantageous to design
molecular beacons to target mRNAs corresponding to
multiple factors, since it is fairly easy to simultaneously
use 3–5 molecular beacons either with the same fluoro-
phore (to enhance signal) or with different fluorophores
(to distinguish different mRNAs). The molecular beacon
based method is likely to be much better than the anti-
body-based method in that the availability of target mol-
ecules (mRNAs) is quite large and the cost of synthesizing
molecular beacons is low compared with that of generat-
ing antibodies (even if multiple cell surface protein mark-
ers are available). The efficiency and specificity of stem
cell detection and isolation can be further enhanced by
targeting mRNAs using multiple molecular beacons and
cell surface markers using antibodies.
For detecting cancer stem cells inside a solid tumor using
tumor tissue, it may be sufficient to target stem cell mark-
ers such as Oct-4 and SSEA-1 in order to positively identify
them, since these markers are highly expressed only in
stem cells, and the tumor type is known in priory. How-
ever, when using other samples such as blood, it will be
necessary to add a marker that is highly expressed only in
specific cancer stem cells so that normal stem cells would
not be taken as cancer stem cells. Identifying such a
marker for the specific tumor type is an important
research topic.
In this work, we have demonstrated the use of molecular
beacons to detect Oct-4 mRNA as a new method for the
detection of cancer stem cells among normal cells or can-
cer cells. A particular issue is whether the biology of cancer
stem cells is affected by the detection method, including
Simultaneous targeting of Oct-4 mRNA and SSEA-1 protein in live P19 cells analyzed by deconvolution microscopy and flow  cytometry Figure 5
Simultaneous targeting of Oct-4 mRNA and SSEA-1 protein in live P19 cells analyzed by deconvolution micro-
scopy and flow cytometry. A. Deconvolution microscopy imaging of Oct-4 mRNA and SSEA-1 protein. Top panel shows 
that targeting of SSEA-1 protein using dye-labeled antibody gave strong signal (green) in undifferentiated (UD) cells and very 
weak signal in RA-treated (differentiated) cells. Random beacons only gave very weak signal (red). Bottom panel shows the flu-
orescence images of simultaneous targeting of Oct-4 mRNA (red) and SSEA-1 protein (green) in undifferentiated (UD) RA-
treated (RA) cells. Scale bar = 15 μM. B. Flow cytometric analysis of signal from targeting Oct-4 mRNA and SSEA-1 protein in 
undifferentiated (top panel) and differentiated (bottom panel) cells. Right and left panels show respectively the results of cells 
with and without MB and SSEA-1 antibody. X- and Y-axis show respectively the relative fluorescence intensities of imaging 
Oct-4 mRNA and SSEA-1 protein.BMC Biotechnology 2009, 9:30 http://www.biomedcentral.com/1472-6750/9/30
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the delivery approach and the probes inside the living cell.
It is unlikely that unbound molecular beacon itself would
affect cell biology such as gene expression and cell differ-
entiation, since the oligonucleotide, fluorophore and
quencher are not toxic. The effect of the delivery method
using streptolysin O (SLO), however, needs to be deter-
mined, since SLO binds to cholesterol molecules on cell
plasma membrane which may cause damages to cell
membrane [28,29]. To address this issue, we delivered 1
μM of MB4 into undifferentiated P19 cells by SLO, and
cultured these cells for 2 weeks. Further, undifferentiated
cells with and without MB4 were cultured for 10 days and
then treated with RA for 4 days (totally 2 weeks). The
mRNA levels of Oct-4 and IGF-2 (Insulin-like Growth Fac-
tor-2) in these cells measured using RT-PCR are shown in
Figure 6. Evidently, cells with and without MB4 had the
same expression levels of Oct-4 (left panel) and IGF-2
(right panel) before and after differentiation, suggesting
that SLO-based beacon delivery and probe/target hybridi-
zation did not have significant effects on cell physiology
including gene expression, self-renewal, and differentia-
tion. We also delivered Oct-4 targeting molecular beacons
by SLO into mouse ESC, ES-D3 cells, for the isolation of
ESCs from their differentiated cells. RT-PCR results and
cell morphologies of differentiated cells with and without
beacon indicated that there was no change in the ability of
stem cell differentiation (unpublished data). To further
establish the molecular beacon based method for detec-
tion and sorting of stem cells (including cancer stem cells
and iPS cells), research is being conducted to demonstrate
the sensitivity, specificity and safety of this technique. The
results will be reported in a subsequent publication.
Conclusion
In this work we have established a novel method for
detecting and isolating stem cells by simultaneously tar-
geting stem cell specific mRNA and protein markers. We
found that molecular beacons can be designed to fluores-
cently image Oct-4 mRNA in cell cytoplasm with high spe-
cificity without disturbing cell physiology. Although there
exist cell surface protein markers for stem cells, their avail-
ability is very limited and therefore, it is very appealing to
detect intracellular stem cell markers such as mRNAs. We
also found that, by performing simultaneous detection of
Oct-4 mRNA using molecular beacons and SSEA-1 pro-
tein on cell surface in a flow cytometric assay, the detec-
tion sensitivity and efficiency can be enhanced. Multiple
beacons can be using to image different mRNAs to further
increase signal level and achieve better specificity. Taken
together, we demonstrated that the detection of specific
mRNAs as stem cell markers using molecular beacons, in
combination with targeting cell surface markers in a flow
cytometric analysis has the potential to provide a power-
ful tool for stem cell research, including the detection of
cancer stem cells and the isolation of iPS cells.
Methods
Cell culture
Mouse EC cells, P19, were purchased from ATCC (CRL-
1825; American Type Culture Collection) and grown in α-
minimum essential medium (Gibco BRL) containing
7.5% calf bovine serum and 2.5% of fetal bovine serum
(Gibco BRL). For differentiation, cells were transferred to
60 mm culture dish with 500 nM all-trans retinoic acid
(RA) (Sigma). 2 days after RA treatment, cells were trans-
ferred without RA and further cultured for 2 days.
Real-time quantitative PCR
Total RNA was isolated from cells using Qiagen RNeasy
Mini Kit. 100 ng of total RNA was used for cDNA synthesis
The effect of Oct-4 targeting molecular beacon (MB4) on  Oct-4 and IGF-2 mRNAs before and after differentiation Figure 6
The effect of Oct-4 targeting molecular beacon 
(MB4) on Oct-4 and IGF-2 mRNAs before and after 
differentiation. Shown in A and B are respectively the rela-
tive amount of Oct-4 and IGF-2 mRNAs in undifferentiated 
(UD) and RA-treated (RA) cells with (MB+) and without 
(MB-) Oct-4 targeting beacon MB4.BMC Biotechnology 2009, 9:30 http://www.biomedcentral.com/1472-6750/9/30
Page 9 of 10
(page number not for citation purposes)
by random hexamers with Invitrogen Thermoscript RT-
PCR kit. For real-time PCR, the cDNA was amplified using
a Stratagene Mx3005P (Stratagene) RT-PCR machine. The
Ambion's 18S primers were used as an internal control for
real-time PCR. PCR amplification was performed with the
following primers with 60°C as the annealing tempera-
ture: Oct-4 sense: 5'-CCGTGTGAGGTGGAGTCTGGAG-3'
and Oct-4 anti-sense: 5'-GCGATGTGAGTGATCTGCTG-
TAGG-3', IGF-2 sense: 5'-GTCGATGTTGGTGCTTCT-
CATCTC-3' and IGF-2 anti-sense: 5'-
GAAGCAGCACTCTTCCACGATG-3'. The Oct-4 mRNA
levels were normalized against the 18S rRNA levels.
Molecular beacon synthesis, delivery and fluorescence 
imaging
Molecular beacons with DNA (2'-deoxy) backbone
labeled with Cy3 fluorophore at the 5' end and Black Hole
quencher 2 (BHQ2) at the 3' end were synthesized by
MWG Biotech (High Point, North Carolina). Molecular
beacons were delivered into live P19 cells cultured in 4-
well chamber with a reversible permeabilization method
using activated SLO [30,31] at the concentration of 0.2 U/
mL in serum free medium for 15 min. After delivery, the
SLO containing medium was changed with the normal
growth medium and incubated for 30 min before fluores-
cence imaging. The fluorescence imaging of live cells was
performed using a Zeiss Axiovert 100 TV epifluorescence
microscope coupled to a Cooke Sensicam SVGA cooled
CCD camera. The confocal imaging was done with Zeiss
Axiovert LSM-100 confocal microscope. The Cy3-labeled
beacons were visualized with excitation at 545 nm and
emission detection at 570 nm. Deconvolution micro-
scopic analysis was carried out using DeltaVision Decon-
volution Microscope (Applied Precision, INC.). The
sequences of all beacons designed and tested are shown in
Table 1, with the underlined sequences as stem sequences.
The numbers were assigned by the order of test for target
specificity. The target sequences of Oct-4 mRNA are also
illustrated in Figure 2. Each molecular beacon experiment
was performed at least 3 times to ensure reproducibility.
Immunocytochemistry analysis
For Oct-4 protein staining, cells were fixed with 4% para-
formaldehyde for 15 min followed by permeabilization
with 0.2% Triton X-100. Cells were blocked with 5% goat
serum in PBS for 30 min at 37°C and incubated with
blocking solution containing mouse monoclonal Oct-4
antibody (Santa Cruz Biotechnology, INC.) for 30 min at
37°C. After washing 3 times, cells were then incubated
with secondary mouse antibody conjugated with Alexa
Fluor 550 (Molecular Probes) for 30 min at 37°C.
Flow cytometric analysis of Oct-4 mRNA and SSEA-1 
protein
P19 cells were detached by Trypsin-EDTA or Enzyme-free
cell dissociation buffer (Invitrogen) and washed once
with serum-free medium. 1 μM of molecular beacons was
delivered using 2 U/mL SLO in serum-free medium for 15
min. After washing, cells were incubated with SSEA-1 anti-
body (1:50, Santa Cruz Biotechnology, INC) for 30 min,
and washed twice and then filtered to obtain single cell
population. Analysis was carried out using FACS Diva
(Beckman Coulter, INC).
Abbreviations
iPS cell: induced pluripotent stem cell; EC cell: embryonal
carcinoma cell; ES cell: embryonic stem cell; RA: retinoic
acid; MB: molecular beacon; SLO: streptolysin O; IGF-2:
Insulin-like Growth Factor-2.
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